- Home
- CSAI vs AIFF Comparison
CSAI vs AIFF Comparison
Compare CSAI & AIFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSAI
- AIFF
- Stock Information
- Founded
- CSAI N/A
- AIFF 2006
- Country
- CSAI
- AIFF United States
- Employees
- CSAI 18
- AIFF N/A
- Industry
- CSAI
- AIFF
- Sector
- CSAI
- AIFF
- Exchange
- CSAI NYSE
- AIFF NYSE
- Market Cap
- CSAI 40.8M
- AIFF 41.5M
- IPO Year
- CSAI N/A
- AIFF N/A
- Fundamental
- Price
- CSAI $1.84
- AIFF $2.74
- Analyst Decision
- CSAI
- AIFF
- Analyst Count
- CSAI 0
- AIFF 0
- Target Price
- CSAI N/A
- AIFF N/A
- AVG Volume (30 Days)
- CSAI N/A
- AIFF 1.4M
- Earning Date
- CSAI N/A
- AIFF 08-18-2025
- Dividend Yield
- CSAI N/A
- AIFF N/A
- EPS Growth
- CSAI N/A
- AIFF N/A
- EPS
- CSAI N/A
- AIFF N/A
- Revenue
- CSAI N/A
- AIFF $139,000.00
- Revenue This Year
- CSAI N/A
- AIFF N/A
- Revenue Next Year
- CSAI N/A
- AIFF N/A
- P/E Ratio
- CSAI N/A
- AIFF N/A
- Revenue Growth
- CSAI N/A
- AIFF N/A
- 52 Week Low
- CSAI N/A
- AIFF $1.86
- 52 Week High
- CSAI N/A
- AIFF $17.20
- Technical
- Relative Strength Index (RSI)
- CSAI N/A
- AIFF 36.25
- Support Level
- CSAI N/A
- AIFF $3.03
- Resistance Level
- CSAI N/A
- AIFF $3.21
- Average True Range (ATR)
- CSAI 0.00
- AIFF 0.25
- MACD
- CSAI 0.00
- AIFF -0.04
- Stochastic Oscillator
- CSAI 0.00
- AIFF 3.74
About CSAI CLOUDASTRUCTURE INC
Cloudastructure Inc is engaged in cloud-based artificial intelligence (AI) video surveillance and Remote Guarding service built on AI and machine learning platforms. Its products/ services include Cloud Video Surveillance, Remote Guarding, Remote Guards, Cloud Video Recorder (CVR), Cameras and Speakers, Mobile Surveillance Trailer, etc.
About AIFF FIREFLY NEUROSCIENCE INC
Firefly Neuroscience Inc is an AI company developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The Company has one reportable segment: the BNA platform. The Company derives revenue from North America.